Products, vehicles, drugs and devices showing sharply rising complaint velocity — a leading indicator of recall risk, often weeks before any official action. Built on public CPSC, openFDA and NHTSA complaint data.
We backtested complaint-velocity against official recalls. Here is exactly how calibrated it is — including how often it's wrong. Sold as risk-triage, never as a prediction.
Ranked by complaint-velocity risk score. Last computed: 2026-09-19 07:21 UTC.
| # | Entity | Band | Risk | Vel /wk | vs base | Accel /wk | Severe | 30d |
|---|---|---|---|---|---|---|---|---|
| 1 | Tesla Model 3 (2023) vehicle · nhtsa · backtested ↑ FORWARD COLLISION AVOIDANCE (43%) |
LOW | 27 | 1.4 | 1.06× | 0.47 | 40% | 6 |
| 2 | Toyota RAV4 (2023) vehicle · nhtsa · backtested ↑ STEERING (40%) |
LOW | 19 | 0.47 | 0.46× | -0.23 | 40% | 2 |
| 3 | Chevrolet Blazer EV (2024) vehicle · nhtsa · backtested ↑ SUSPENSION (100%) |
LOW | 18 | 0.23 | 0.33× | -0.23 | 33% | 1 |
| 4 | Tesla Cybertruck (2024) vehicle · nhtsa · backtested ↑ STRUCTURE (50%) |
BASELINE | 17 | 0.47 | 0.4× | -0.7 | 29% | 2 |
| 5 | Ford Mustang Mach-E (2022) vehicle · nhtsa · backtested |
BASELINE | 16 | 0 | 0× | -0.23 | 100% | 0 |
| 6 | Tesla Model Y (2023) vehicle · nhtsa · backtested ↑ STEERING (22%) |
BASELINE | 13 | 3.5 | 0.9× | 0.47 | 18% | 15 |
| 7 | Beta Bionics iLet device · fda_device |
BASELINE | 12 | 353.27 | 0.35× | -768.6 | 26% | 1,514 |
| 8 | Honda CR-V (2023) vehicle · nhtsa · backtested ↑ STEERING (33%) |
BASELINE | 11 | 1.4 | 0.82× | 0.47 | 10% | 6 |
| 9 | Jeep Grand Cherokee (2022) vehicle · nhtsa · backtested ↑ ELECTRICAL SYSTEM (56%) |
BASELINE | 11 | 1.17 | 0.58× | -0.7 | 0% | 5 |
| 10 | Toyota RAV4 (2024) vehicle · nhtsa · backtested ↑ ELECTRICAL SYSTEM (33%) |
BASELINE | 11 | 0.93 | 0.86× | 0 | 13% | 4 |
| 11 | Kia EV6 (2023) vehicle · nhtsa · backtested ↑ POWER TRAIN (33%) |
BASELINE | 9 | 0.23 | 0.27× | -0.93 | 17% | 1 |
| 12 | Medtronic MiniMed 780G device · fda_device |
BASELINE | 9 | 435.17 | 0.33× | -768.6 | 21% | 1,865 |
| 13 | Ford F-350 Crew Cab (2021) vehicle · nhtsa · backtested ↑ FUEL SYSTEM (33%) |
BASELINE | 7 | 0.47 | 1.2× | -0.23 | 0% | 2 |
| 14 | Tandem t:slim X2 Pump device · fda_device |
BASELINE | 4 | 1260.23 | 0.35× | -2760.57 | 10% | 5,401 |
| 15 | Ford Mustang Mach-E (2021) vehicle · nhtsa · backtested ↑ ELECTRICAL SYSTEM (33%) |
BASELINE | 3 | 0.47 | 0.5× | 0 | 0% | 2 |
| 16 | Dexcom G7 CGM device · fda_device |
BASELINE | 1 | 1556.33 | 0.37× | -3551.8 | 2% | 6,670 |
| 17 | Chevrolet Bolt EV (2022) vehicle · nhtsa · backtested |
BASELINE | 0 | 0 | 0× | 0 | 0% | 0 |
| 18 | Honda Prologue (2024) vehicle · nhtsa |
BASELINE | 0 | — | — | — | — | — |
| 19 | Philips DreamStation CPAP device · fda_device |
BASELINE | 0 | 29.17 | 0.02× | -792.4 | 0% | 125 |
| 20 | Ozempic (semaglutide) drug · fda_drug |
BASELINE | 0 | 0 | 0× | 0 | 0% | 0 |
| 21 | Wegovy (semaglutide) drug · fda_drug |
BASELINE | 0 | 0 | 0× | 0 | 0% | 0 |
| 22 | Mounjaro (tirzepatide) drug · fda_drug |
BASELINE | 0 | 0 | 0× | 0 | 0% | 0 |
| 23 | Humira (adalimumab) drug · fda_drug |
BASELINE | 0 | 0 | 0× | 0 | 0% | 0 |
| 24 | Eliquis (apixaban) drug · fda_drug |
BASELINE | 0 | 0 | 0× | 0 | 0% | 0 |
| 25 | Ford F-150 Lightning (2023) vehicle · nhtsa |
BASELINE | 0 | — | — | — | — | — |
Sources: CPSC SaferProducts · openFDA (drug & device adverse events) · NHTSA complaints.
Every flagged entity is cross-checked daily against real CPSC / FDA / NHTSA recall feeds. When a flagged product is later recalled, we publish the lead time.
Free weekly digest of the top rising-risk products. Retailers, insurers and class-action firms — see the paid feed/API/webhook tiers.